Comments
Loading...

Altimmune

ALTNASDAQ
Logo brought to you by Benzinga Data
$7.55
-0.21-2.71%
At close: -
$7.55
0.000.00%
After Hours: 4:54 PM EDT

Altimmune (NASDAQ:ALT) Stock Quotes, Forecast and News Summary

Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.

Open$7.76
Close$7.55
Volume / Avg.1.34M / 3.07M
Day Range$7.50 - $7.80
52 Wk Range5.28 - 14.84
Market Cap$536.99M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
45
Short Interest
33.04%
Days to Cover6.1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
Aug
2
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$7.76
Close$7.55
Volume / Avg.1.34M / 3.07M
Day Range$7.50 - $7.80
52 Wk Range5.28 - 14.84
Market Cap$536.99M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
45
Short Interest
33.04%
Days to Cover6.1

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ALT
HUMA

FAQ

Q

How do I buy Altimmune (ALT) stock?

A

You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Altimmune (ALT) competitors?

Q

What is the forecast, or price target, for Altimmune (ALT) stock?

A

Altimmune has a consensus price target of $22.50.

Q

What is the current price for Altimmune (ALT)?

A

The stock price for Altimmune (NASDAQ: ALT) is $7.55 last updated December 24, 2024 at 4:54 PM EST.

Q

Does Altimmune (ALT) pay a dividend?

A

There are no upcoming dividends for Altimmune.

Q

When is Altimmune (NASDAQ:ALT) reporting earnings?

A

Altimmune’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Q

Is Altimmune (ALT) going to split?

A

There is no upcoming split for Altimmune.

Q

What sector and industry does Altimmune (ALT) operate in?

A

Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch